未登录

M

Marco Pozzi

scientific institute irccs eugenio medea

H指数:34

被引数:3,977

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy

抗精神病药物与饮食干预：药效学、药代动力学及治疗中的协同作用

Pharmacological Reviews

IF17.3

2025-04-290

OAAI

Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients

TRANSLATIONAL PSYCHIATRY

IF6.2

2024-01-084

OAAI

Updated Considerations for the Immunopharmacological Aspects of the Talented mRNA Vaccines

IF3.4

2023-09-123

OAAI

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression

FRONTIERS IN PSYCHIATRY

IF3.2

2023-07-1212

OAAI

Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy

INTERNAL AND EMERGENCY MEDICINE

IF3.8

2023-02-284

OAAI

Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study

PSYCHIATRY AND CLINICAL NEUROSCIENCES

IF6.2

2022-12-2112

OA

Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects

CARDIOVASCULAR RESEARCH

IF13.3

2022-07-2821

OAAI

Bicuspid Aortic Valve in Children and Adolescents: A Comprehensive Review

IF3.3

2022-07-2014

OAAI

Reply to: correspondence on Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis

EXPERT REVIEW OF VACCINES

IF4.8

2022-05-170

OA

Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis

EXPERT REVIEW OF VACCINES

IF4.8

2022-02-2532

PRE

Syndromic and Non-Syndromic Patients with Repaired Tetralogy of Fallot: Does It Affect the Long-Term Outcome?

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-02-064

OAAI

Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis Following mRNA COVID-19 Vaccination: A Case Series

IF3.4

2022-01-2218

OAAI

The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2021-07-0739

PREAI

Foetal ductus arteriosus constriction unrelated to non-steroidal anti-Inflammatory drugs: a case report and literature review

与非甾体抗炎药无关的胎儿动脉导管缩窄1例报告并文献复习

ANNALS OF MEDICINE

IF4.3

2021-06-077

OAAI

Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression

PSYCHOLOGICAL MEDICINE

IF5.5

2021-02-2419

PREAI

We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database

FRONTIERS IN PSYCHIATRY

IF3.2

2020-12-0211

OAAI

Drug Use in Pediatric Patients Admitted to Rehabilitation For Severe Acquired Brain Injury: Analysis of the Associations With Rehabilitation Outcomes

PEDIATRIC DRUGS

IF3.3

2020-11-242

PREAI

Metabolic disorders induced by antipsychotic drugs: clinical findings in support of non-psychopharmacological mechanisms of action

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

PREAI

Hemodynamic response to methylphenidate in children with attention deficit hyperactivity disorder: first administration, titration phase and associations with clinical severity

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

PREAI

Metabolic disorders induced by antipsychotic drugs: in vitro study of the mechanisms of action

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

PREAI